Jeffrey Rice, PhD
National Institute of Allergy and Infectious Diseases (NIH/NIAID)
Rockville, Maryland, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Carla Cuda, PhD
Northwestern University
Chicago, Illinois, United States
Disclosure information not submitted.
Investigators from NIAID’s autoimmune diseases research program will present their cutting-edge research on innate immune mechanisms involved in the pathogenesis of autoimmune disease. The investigators will discuss recent evidence of the involvement of different innate immune cells and pathways and discuss new therapeutic targets directed against innate immune components as potential novel therapies. These advances may enable clinicians to better understand of the pathogenesis and molecular mechanisms underlying the clinical manifestations of autoimmune disease and more effectively manage the disease through more precise targeting of pathogenic cell subsets, minimizing off-target effects and reducing the use of systemic immunosuppression.
Speaker: Jin Billy Li, PhD – Stanford University
Speaker: Ram Savan, PhD – University of Washington
Speaker: Ann Marshak-Rothstein, PhD – UMass Chan Medical School